Published in Transplantation on October 01, 1991
Cloning and sequence analysis of the rat augmenter of liver regeneration (ALR) gene: expression of biologically active recombinant ALR and demonstration of tissue distribution. Proc Natl Acad Sci U S A (1994) 2.35
A fresh look at augmenter of liver regeneration in rats. Hepatology (1999) 1.32
Analysis of the structure and expression of the augmenter of liver regeneration (ALR) gene. Mol Med (1996) 1.16
Effects of rapamycin on cultured hepatocyte proliferation and gene expression. Hepatology (1992) 1.06
The in vivo effect of hepatotrophic factors augmenter of liver regeneration, hepatocyte growth factor, and insulin-like growth factor-II on liver natural killer cell functions. Hepatology (1997) 1.04
Hepatic regeneration and growth factors. J Surg Oncol Suppl (1993) 1.01
Inhibition of liver, kidney, and intestine regeneration by rapamycin. Transplantation (1992) 1.00
Effect on the canine Eck fistula liver of intraportal TGF-beta alone or with hepatic growth factors. Hepatology (1992) 0.89
Small-for-size liver transplanted into larger recipient: a model of hepatic regeneration. Hepatology (1994) 0.79
Cyclophilin and peptidyl-prolyl cis-trans isomerase are probably identical proteins. Nature (1989) 8.48
A receptor for the immunosuppressant FK506 is a cis-trans peptidyl-prolyl isomerase. Nature (1989) 7.02
Chemistry and biology of the immunophilins and their immunosuppressive ligands. Science (1991) 6.80
A cytosolic binding protein for the immunosuppressant FK506 has peptidyl-prolyl isomerase activity but is distinct from cyclophilin. Nature (1989) 5.53
Effects of insulin, glucagon, and insuling/glucagon infusions on liver morphology and cell division after complete portacaval shunt in dogs. Lancet (1976) 3.74
Two distinct signal transmission pathways in T lymphocytes are inhibited by complexes formed between an immunophilin and either FK506 or rapamycin. Proc Natl Acad Sci U S A (1990) 3.70
Molecular cloning and overexpression of the human FK506-binding protein FKBP. Nature (1990) 3.02
Hepatotrophic effects of FK506 in dogs. Transplantation (1991) 2.39
The hepatotropic influence of cyclosporine. Surgery (1990) 2.27
Augmentation of rat liver regeneration by FK 506 compared with cyclosporin. Lancet (1989) 2.01
Overproduction and dissection of proteins by the expression-cassette polymerase chain reaction. Proc Natl Acad Sci U S A (1990) 1.77
The refolding of urea-denatured ribonuclease A is catalyzed by peptidyl-prolyl cis-trans isomerase. Biochim Biophys Acta (1985) 1.75
Isolation and sequence of an FK506-binding protein from N. crassa which catalyses protein folding. Nature (1990) 1.74
Transplantation. JAMA (1990) 1.71
Distribution of the cyclosporine binding protein cyclophilin in human tissues. Immunology (1991) 1.13
Cyclosporin A inhibits degranulation of rat basophilic leukemia cells and human basophils. Inhibition of mediator release without affecting PI hydrolysis or Ca2+ fluxes. J Immunol (1990) 1.05
Evolution of liver transplantation. Hepatology (1982) 19.54
Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell (1991) 15.76
A mammalian histone deacetylase related to the yeast transcriptional regulator Rpd3p. Science (1996) 12.64
Small molecule inhibitor of mitotic spindle bipolarity identified in a phenotype-based screen. Science (1999) 12.52
A mammalian protein targeted by G1-arresting rapamycin-receptor complex. Nature (1994) 11.50
Atomic structures of the human immunophilin FKBP-12 complexes with FK506 and rapamycin. J Mol Biol (1993) 11.24
Printing proteins as microarrays for high-throughput function determination. Science (2000) 10.77
Nuclear receptor repression mediated by a complex containing SMRT, mSin3A, and histone deacetylase. Cell (1997) 8.99
Inhibition of proteasome activities and subunit-specific amino-terminal threonine modification by lactacystin. Science (1995) 8.58
Orthotopic liver transplantation in ninety-three patients. Surg Gynecol Obstet (1976) 8.11
The use of cyclosporin A and prednisone in cadaver kidney transplantation. Surg Gynecol Obstet (1980) 7.40
The use of heterologous antilymphoid agents in canine renal and liver homotransplantation and in human renal homotransplantation. Surg Gynecol Obstet (1967) 7.24
Fifteen years of clinical liver transplantation. Gastroenterology (1979) 7.19
Control of p70 s6 kinase by kinase activity of FRAP in vivo. Nature (1995) 7.05
A receptor for the immunosuppressant FK506 is a cis-trans peptidyl-prolyl isomerase. Nature (1989) 7.02
Liver transplantation with use of cyclosporin a and prednisone. N Engl J Med (1981) 6.95
Controlling signal transduction with synthetic ligands. Science (1993) 6.70
Orthotopic homotransplantation of the human liver. Ann Surg (1968) 6.64
Three proteins define a class of human histone deacetylases related to yeast Hda1p. Proc Natl Acad Sci U S A (1999) 6.50
Structural basis for the binding of proline-rich peptides to SH3 domains. Cell (1994) 6.34
Histone deacetylase activity is required for full transcriptional repression by mSin3A. Cell (1997) 6.27
Structure of the FKBP12-rapamycin complex interacting with the binding domain of human FRAP. Science (1996) 5.92
Rapamycin-modulated transcription defines the subset of nutrient-sensitive signaling pathways directly controlled by the Tor proteins. Proc Natl Acad Sci U S A (1999) 5.89
Chromatin deacetylation by an ATP-dependent nucleosome remodelling complex. Nature (1998) 5.84
Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy. Lancet (1984) 5.74
Progress in and deterrents to orthotopic liver transplantation, with special reference to survival, resistance to hyperacute rejection, and biliary duct reconstruction. Transplant Proc (1974) 5.53
Extended survival in 3 cases of orthotopic homotransplantation of the human liver. Surgery (1968) 5.44
Overexpression of a kinase-inactive ATR protein causes sensitivity to DNA-damaging agents and defects in cell cycle checkpoints. EMBO J (1998) 5.25
Cyclophosphamide and whole organ transplantation in human beings. Surg Gynecol Obstet (1971) 5.24
Regulation of histone deacetylase 4 and 5 and transcriptional activity by 14-3-3-dependent cellular localization. Proc Natl Acad Sci U S A (2000) 5.18
Two binding orientations for peptides to the Src SH3 domain: development of a general model for SH3-ligand interactions. Science (1994) 4.57
PIK-related kinases: DNA repair, recombination, and cell cycle checkpoints. Science (1995) 4.51
Biliary complications after liver transplantation: with special reference to the biliary cast syndrome and techniques of secondary duct repair. Surgery (1977) 4.08
Identification of an 11-kDa FKBP12-rapamycin-binding domain within the 289-kDa FKBP12-rapamycin-associated protein and characterization of a critical serine residue. Proc Natl Acad Sci U S A (1995) 3.87
The preparation and testing of horse antidog and antihuman antilymphoid plasma or serum and its protein fractions. Surg Gynecol Obstet (1967) 3.86
A role for histone deacetylase activity in HDAC1-mediated transcriptional repression. Proc Natl Acad Sci U S A (1998) 3.85
The origin, hormonal nature, and action of hepatotrophic substances in portal venous blood. Surg Gynecol Obstet (1973) 3.84
Effects of insulin, glucagon, and insuling/glucagon infusions on liver morphology and cell division after complete portacaval shunt in dogs. Lancet (1976) 3.74
Selection of gp41-mediated HIV-1 cell entry inhibitors from biased combinatorial libraries of non-natural binding elements. Nat Struct Biol (1999) 3.72
Two distinct signal transmission pathways in T lymphocytes are inhibited by complexes formed between an immunophilin and either FK506 or rapamycin. Proc Natl Acad Sci U S A (1990) 3.70
CoREST is an integral component of the CoREST- human histone deacetylase complex. Proc Natl Acad Sci U S A (2001) 3.66
Transplantation of multiple abdominal viscera. JAMA (1989) 3.59
TOR kinase domains are required for two distinct functions, only one of which is inhibited by rapamycin. Cell (1995) 3.56
Canine liver transplantation under Nva2-cyclosporine versus cyclosporine. Transplantation (1986) 3.54
Protein phosphatase 2A interacts with the 70-kDa S6 kinase and is activated by inhibition of FKBP12-rapamycinassociated protein. Proc Natl Acad Sci U S A (1999) 3.49
Cadaveric renal transplantation. An analysis of 65 cases. Lancet (1969) 3.48
Genomewide studies of histone deacetylase function in yeast. Proc Natl Acad Sci U S A (2000) 3.46
Selected topics on FK 506, with special references to rescue of extrahepatic whole organ grafts, transplantation of "forbidden organs," side effects, mechanisms, and practical pharmacokinetics. Transplant Proc (1991) 3.40
cDNA cloning and gene mapping of a candidate human cell cycle checkpoint protein. Proc Natl Acad Sci U S A (1996) 3.31
A signaling pathway to translational control. Cell (1996) 3.29
Use of OKT3 with cyclosporin and steroids for reversal of acute kidney and liver allograft rejection. Nephron (1987) 3.26
Delayed biliary duct obstruction after orthotopic liver transplantation. Surgery (1972) 3.26
Partitioning the transcriptional program induced by rapamycin among the effectors of the Tor proteins. Curr Biol (2001) 3.26
Inhibition of T cell signaling by immunophilin-ligand complexes correlates with loss of calcineurin phosphatase activity. Biochemistry (1992) 3.05
Molecular cloning and overexpression of the human FK506-binding protein FKBP. Nature (1990) 3.02
Chronic survival after human renal homotransplantation. Lymphocyte-antigen matching, pathology and influence of thymectomy. Ann Surg (1965) 3.00
Cyclosporin A and steroid therapy in sixty-six cadaver kidney recipients. Surg Gynecol Obstet (1981) 2.92
Atomic structure of FKBP-FK506, an immunophilin-immunosuppressant complex. Science (1991) 2.83
Studies of homograft sex and of gamma globulin phenotypes after orthotopic homotransplantation of the human liver. Surg Forum (1969) 2.80
Identification of a class of small molecule inhibitors of the sirtuin family of NAD-dependent deacetylases by phenotypic screening. J Biol Chem (2001) 2.80
ATR inhibition selectively sensitizes G1 checkpoint-deficient cells to lethal premature chromatin condensation. Proc Natl Acad Sci U S A (2001) 2.75
Nuclear histone acetylases and deacetylases and transcriptional regulation: HATs off to HDACs. Curr Opin Chem Biol (1997) 2.73
FKBP12-rapamycin-associated protein (FRAP) autophosphorylates at serine 2481 under translationally repressive conditions. J Biol Chem (2000) 2.72
A new therapeutic approach for hydatid liver cysts. Aspiration and alcohol injection under sonographic guidance. Gastroenterology (1990) 2.68
Small molecule developmental screens reveal the logic and timing of vertebrate development. Proc Natl Acad Sci U S A (2000) 2.67
Complete amino acid sequence of the FK506 and rapamycin binding protein, FKBP, isolated from calf thymus. J Protein Chem (1991) 2.62
Growth-stimulating factor in regenerating canine liver. Lancet (1979) 2.61
Studies of blood flow and ultrastructural changes in rejecting and nonrejecting canine orthotopic liver homografts. Surgery (1968) 2.58
Solution structure of the SH3 domain of Src and identification of its ligand-binding site. Science (1992) 2.56
Detection of circulating immune complexes in pathological human sera. Lancet (1975) 2.51
Liver transplantation, 1980, with particular reference to cyclosporin-A. Transplant Proc (1981) 2.49
Acute neurological complications after liver transplantation with particular reference to intraoperative cerebral air embolus. Ann Surg (1978) 2.48
Portal diversion for the treatment of glycogen storage disease in humans. Ann Surg (1973) 2.44
Hepatotrophic effects of FK506 in dogs. Transplantation (1991) 2.39
Immunosuppressants implicate protein phosphatase regulation of K+ channels in guard cells. Proc Natl Acad Sci U S A (1993) 2.39
The Eck fistula in animals and humans. Curr Probl Surg (1983) 2.35
Cloning and sequence analysis of the rat augmenter of liver regeneration (ALR) gene: expression of biologically active recombinant ALR and demonstration of tissue distribution. Proc Natl Acad Sci U S A (1994) 2.35
Lactacystin, proteasome function, and cell fate. J Biol Chem (1998) 2.33
Portacaval shunt in patients with familial hypercholesterolemia. Ann Surg (1983) 2.33
Dimeric ligands define a role for transcriptional activation domains in reinitiation. Nature (1996) 2.29
The hepatotropic influence of cyclosporine. Surgery (1990) 2.27
SEROTYPING FOR HOMOTRANSPLANTATION. VII. SELECTION OF KIDNEY DONORS FOR THIRTY-TWO RECIPIENTS. Ann N Y Acad Sci (1966) 2.25
Controlling protein association and subcellular localization with a synthetic ligand that induces heterodimerization of proteins. Proc Natl Acad Sci U S A (1996) 2.20
The transport of pyruvate in rat liver mitochondria. FEBS Lett (1971) 2.19
Dimerization as a regulatory mechanism in signal transduction. Annu Rev Immunol (1998) 2.17
Cloning, expression, and purification of human cyclophilin in Escherichia coli and assessment of the catalytic role of cysteines by site-directed mutagenesis. Proc Natl Acad Sci U S A (1990) 2.14
Human cadaveric renal transplantation. Report of twenty cases. Br Med J (1965) 2.12
Histone deacetylase 1 phosphorylation promotes enzymatic activity and complex formation. J Biol Chem (2001) 2.08
Human renal transplants. I. Glomerular changes. Lab Invest (1967) 2.06
Alpha 4 associates with protein phosphatases 2A, 4, and 6. Biochem Biophys Res Commun (1998) 2.03